GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Trajan Group Holdings Ltd (OTCPK:TRJNF) » Definitions » YoY EBITDA Growth

TRJNF (Trajan Group Holdings) YoY EBITDA Growth : 25.00% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Trajan Group Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Trajan Group Holdings's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 25.00%.

Trajan Group Holdings's EBITDA per Share for the six months ended in Dec. 2024 was $0.01.

Trajan Group Holdings YoY EBITDA Growth Historical Data

The historical data trend for Trajan Group Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trajan Group Holdings YoY EBITDA Growth Chart

Trajan Group Holdings Annual Data
Trend Jun21 Jun22 Jun23 Jun24
YoY EBITDA Growth
- -61.67 173.91 -244.44

Trajan Group Holdings Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only 700.00 57.89 -75.00 -430.00 25.00

Trajan Group Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Trajan Group Holdings's YoY EBITDA Growth for the fiscal year that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (A: Jun. 2024 )
=(EBITDA per Share (A: Jun. 2024 )-EBITDA per Share (A: Jun. 2023 ))/ | EBITDA per Share (A: Jun. 2023 ) |
=(-0.091-0.063)/ | 0.063 |
=-244.44 %

Trajan Group Holdings's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(0.01-0.008)/ | 0.008 |
=25.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trajan Group Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Trajan Group Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Trajan Group Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Trajan Group Holdings Ltd (OTCPK:TRJNF) » Definitions » YoY EBITDA Growth
Comparable Companies
ASX:AHC ASX:SDI ASX:OSX ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN COO BAX WST ALGN HOLX NZSE:FPH SOLV
Traded in Other Exchanges
TRJ:Australia
Address
7 Argent Place, Ringwood, VIC, AUS, 3134
Website
https://www.trajanscimed.com
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental sample. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and Consumables that includes parts, supplies, components and consumable products across the world. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).